CN106857856A - 一种有益于呼吸系统的复合益生菌产品 - Google Patents
一种有益于呼吸系统的复合益生菌产品 Download PDFInfo
- Publication number
- CN106857856A CN106857856A CN201710026861.0A CN201710026861A CN106857856A CN 106857856 A CN106857856 A CN 106857856A CN 201710026861 A CN201710026861 A CN 201710026861A CN 106857856 A CN106857856 A CN 106857856A
- Authority
- CN
- China
- Prior art keywords
- parts
- beneficial
- respiratory system
- powder
- compound probiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 11
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 11
- 230000009286 beneficial effect Effects 0.000 title claims abstract description 10
- 150000001875 compounds Chemical class 0.000 title claims abstract description 9
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 9
- 210000002345 respiratory system Anatomy 0.000 title claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 16
- 241000234435 Lilium Species 0.000 claims abstract description 10
- 235000008939 whole milk Nutrition 0.000 claims abstract description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 5
- 239000005862 Whey Substances 0.000 claims abstract description 5
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 5
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 5
- 235000013312 flour Nutrition 0.000 claims abstract description 5
- 239000008103 glucose Substances 0.000 claims abstract description 5
- 241000194020 Streptococcus thermophilus Species 0.000 claims abstract description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 3
- 239000008101 lactose Substances 0.000 claims abstract description 3
- 241000186660 Lactobacillus Species 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 abstract description 4
- 239000004376 Sucralose Substances 0.000 abstract description 4
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 abstract description 4
- 235000019408 sucralose Nutrition 0.000 abstract description 4
- 241000411851 herbal medicine Species 0.000 abstract description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 208000023504 respiratory system disease Diseases 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 229940099908 multivitamin and calcium Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000002815 pulmonary hypertension Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/156—Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开一种有益于呼吸系统的复合益生菌产品，其含有嗜热链球菌、鼠李糖乳杆菌、低聚果糖、乌梅粉、百合粉、玉竹粉、三氯蔗糖、全脂奶粉、乳清蛋白粉、乳糖、葡萄糖。本发明采用高科技的益生菌与中草药中的天然成分配伍使用，补足营养，有益于呼吸系统。
Description
技术领域
本发明涉及一种复合益生菌产品，尤其是涉及一种有益于呼吸系统的复合益生菌产品。
背景技术
呼吸系统疾病据全国部分城市及农村前十位主要疾病死亡原因的统计数，呼吸系统疾病(不包括肺癌)在城市的死亡病因中占第四位(13．1%)，在农村占第三位(16．4%)。由于大气污染、吸烟、工业经济发展导致的理化因子、生物因子吸人以及人口年龄老化等因素，使近年来呼吸系统疾病如肺癌、支气管哮喘的发病率明显增加，慢性阻塞性肺疾病居高不下(40岁以上人群中超过8%)。肺结核发病率虽有所控制，但近年又有增高趋势。 肺血栓栓塞症已经构成了重要的医疗保健问题，肺动脉高压近年来也日益受到关注。肺部弥漫性间质纤维化及免疫低下性肺部感染等疾病发病率日渐增多。目前在多个国家出现的人禽流感病死率超过60%。而禽流感病毒侵人体内主要的靶器官也是肺。这正说明呼吸系统疾病对我国人民健康危害仍是很大的，其防治任务艰巨。
发明内容
本发明的目的是提供了一种包含益生菌、中草药有效成分等的复合益生菌食品，可以起到有益于呼吸系统的作用。
本发明是以如下技术方案实现的：一种有益于呼吸系统的复合益生菌产品含有嗜热链球菌1-3份、鼠李糖乳杆菌3-8份、低聚果糖80-120份、乌梅粉15-25份、百合粉20-40份、玉竹粉10-30份、三氯蔗糖0.1-0.5份、全脂奶粉100-300份、乳清蛋白粉10-30份、乳糖80-120份、葡萄糖60-150份。
乳清蛋白是采用先进工艺从牛奶分离提取出来的珍贵蛋白质，以其纯度高、吸收率高、氨基酸组成最合理等诸多优势被推为“蛋白之王”。 提供身体构造新组织所需的氨基酸，延缓人体衰老，调节体内的水分、电解质平衡，增强机体抗疲劳能力，在体内制造酶，改善肠胃功能，向细胞输送氧和各种营养物质，加速机体修复。
全脂奶粉含有牛奶中的优质蛋白质、脂肪、多种维生素以及钙、磷、铁等矿物质。
低聚果糖是一种水溶性膳食纤维，能有效降低血清胆固醇、甘油三脂、游离脂肪酸的数量，在大肠内被细菌发酵生成L－乳酸，可以溶解钙、镁、铁等矿物质，促进人体对矿物质的吸收。还可促进维生素B1、B2、B3、B6、B12及叶酸的自然形成，从而提高人体新陈代谢水平，提高免疫力和抗病力。
乌梅属药食同源，味酸、涩，平。归肝、脾、肺、大肠经，能敛肺止咳。
玉竹：味甘、平，入为、肺经。玉竹能滋阴润肺，生津止渴。玉竹里的多糖、维他命A与烟酸，能够增强人体抗病能力，推迟衰老。
百合：百合味甘、性平，入心、肺经。百合有润肺止咳、清心安神作用，可用于肺痨咯血、肺虚久咳、虚烦惊悸、失眠及热病后余热未清、心烦口渴等症。百合富含钾，有利于加强肌肉兴奋度，促使代谢功能协调。
乌梅、百合、玉竹三者均入肺经，具有养肺养阴，清热生津之效，三者配伍，相互增其疗效。杆菌对于过敏体质有很好的缓解作用， 平衡和改善胃肠道功能， 增强人体自身免疫能力，预防呼吸道感染。
本发明的有益效果是：本发明将现代营养学研究成果与传统养生保健理论相结合，研制出了一种有益于呼吸系统的复合益生菌产品。通过各种配料的有机组合，将各种功能进行融合，并通过有效成分之间的协同作用，增强作用效果。且口感良好、风味独特。工艺简单，易操作，适宜工厂规模化生产。
具体实施方式
下面结合实施例对本发明做进一步描述。
实施例1
本实施例的组分及重量份数为：嗜热链球菌2份、鼠李糖乳杆菌4份、低聚果糖90份、乌梅粉18份、百合粉24份、玉竹粉12份、三氯蔗糖0.3份、全脂奶粉120份、乳清蛋白粉15份、乳糖90份、葡萄糖70份。
将上述原料混合，搅拌均匀，经过干燥，制成粉状食品。用一定量温开水冲调后，可直接食用。
实施例2
本实施例的组分及重量份数为：嗜热链球菌1份、鼠李糖乳杆菌7份、低聚果糖100份、乌梅粉21份、百合粉260份、玉竹粉22份、三氯蔗糖0.3份、全脂奶粉150份、乳清蛋白粉24份、乳糖110份、葡萄糖80份。
将上述原料混合，搅拌均匀，经过干燥，制成粉状食品。用一定量温开水冲调后，可直接食用。
以上对本发明进行了详细介绍，以上实施例的说明只是用于帮助理解本发明。本领域的普通技术人员应当理解，可以对本发明的技术方案进行更动、润饰或者等同替换，而不脱离本发明技术方案的精神和范围，其均应属于本发明的权利要求保护范围当中。
Claims (1)
1.一种有益于呼吸系统的复合益生菌产品，其特征在于它含有嗜热链球菌1-3份、鼠李糖乳杆菌3-8份、低聚果糖80-120份、乌梅粉15-25份、百合粉20-40份、玉竹粉10-30份、三氯蔗糖0.1-0.5份、全脂奶粉100-300份、乳清蛋白粉10-30份、乳糖80-120份、葡萄糖60-150份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710026861.0A CN106857856A (zh) | 2017-01-14 | 2017-01-14 | 一种有益于呼吸系统的复合益生菌产品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710026861.0A CN106857856A (zh) | 2017-01-14 | 2017-01-14 | 一种有益于呼吸系统的复合益生菌产品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106857856A true CN106857856A (zh) | 2017-06-20 |
Family
ID=59158058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710026861.0A Pending CN106857856A (zh) | 2017-01-14 | 2017-01-14 | 一种有益于呼吸系统的复合益生菌产品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106857856A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019055665A1 (en) * | 2017-04-24 | 2019-03-21 | Knoze Jr Corporation | COMPOSITION FOR PROMOTING ORAL MICROBIOTE |
-
2017
- 2017-01-14 CN CN201710026861.0A patent/CN106857856A/zh active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019055665A1 (en) * | 2017-04-24 | 2019-03-21 | Knoze Jr Corporation | COMPOSITION FOR PROMOTING ORAL MICROBIOTE |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104207146A (zh) | 呼吸系统疾病全营养配方食品 | |
| CN101869162A (zh) | 一种灵芝茶及其制备方法 | |
| CN104782773A (zh) | 一种复合花生奶生产方法 | |
| CN105192063A (zh) | 一种百香果酸奶 | |
| CN110574918A (zh) | 一种健脾固本的保健食品 | |
| CN104839662A (zh) | 呼吸系统疾病医学配方食品 | |
| CN102657304B (zh) | 一种具有促进消化和缓解体力疲劳双功能的保健食品 | |
| CN107028188A (zh) | 黄精植物提取液、发酵酸奶及其制备方法 | |
| CN104172168A (zh) | 一种调理动脉粥样硬化的方便食品 | |
| CN106360683A (zh) | 一种铁皮石斛香蕉复合益生菌发酵产品及其方法 | |
| CN103598325A (zh) | 一种茯苓保健酸奶及其制作方法 | |
| CN102726735A (zh) | 一种灵芝孢子蜜及其制备方法 | |
| CN103238889A (zh) | 一种抗疲劳苹果醋保健饮料及其制备方法 | |
| CN106890274A (zh) | 润肺止咳茶 | |
| CN102960736A (zh) | 一种保健食品及其制备方法 | |
| CN104921132A (zh) | 一种具有润肺止咳消喘功效的中草药保健口服液 | |
| CN104855974A (zh) | 呼吸系统疾病非全营养配方食品 | |
| CN107950850A (zh) | 一种益胃生津、滋阴清热的石斛固体饮料的制备方法及应用 | |
| CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
| CN106857856A (zh) | 一种有益于呼吸系统的复合益生菌产品 | |
| CN106520493A (zh) | 一种枇杷果酒及其制备方法 | |
| CN105985895A (zh) | 一种养生酒及其制备工艺 | |
| CN105106928A (zh) | 一种灵芝蛋白粉及其制备方法 | |
| CN101766306A (zh) | 美体金针菇多糖保健胶囊 | |
| CN106857943A (zh) | 一种保健茶 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170620 |
|
| WD01 | Invention patent application deemed withdrawn after publication |